Complete cure with brigatinib/brigatinib

Brigatinib is a targeted drug used to treat ALK-positive non-small cell lung cancer. It blocks tumor growth and spread by inhibiting the activity of the ALK protein. Non-small cell lung cancer is a complex disease, and treatment options are often individualized and customized based on factors such as the patient's condition, stage and genetic mutations. Although brigatinib can achieve good therapeutic effects in some patients, it does not guarantee complete tumor cure in all patients.

Non-small cell lung cancer may have different mutations, including ALK fusion gene mutations as well as various other cancer-causing mutations. These mutations may cause tumors to become resistant to treatment, reducing the likelihood of cure. Brigatinib can inhibit the activity of ALK fusion genes, but may not be sensitive to other mutations. Brigatinib is available as an oral tablet. Usually taken once daily, with or without food. Patients should take brigatinib strictly as directed and do not take too much, too little, or more often than prescribed by the doctor. Doctors may start patients on a low dose of brigatinib and increase the dose after 7 days of treatment.

In addition, the treatment of lung cancer often requires a combination of multiple methods, including surgery, radiotherapy, chemotherapy, etc. As one of the treatments, brigatinib often needs to be combined with other treatments to form a comprehensive treatment plan. Through comprehensive treatment, the treatment effect can be further improved and the patient's survival period can be prolonged.

In summary, although brigatinib is an effective treatment for lung cancer, it cannot completely cure lung cancer. During the treatment process, it is necessary to comprehensively consider the patient's specific situation and the comprehensive application of multiple treatment methods to achieve the best treatment effect. At the same time, drugs need to be used under the guidance of professional doctors to ensure patient safety and rational use of drugs.